WO1991000045A1 - Reactif pour la detection de siv et hiv-2 - Google Patents
Reactif pour la detection de siv et hiv-2 Download PDFInfo
- Publication number
- WO1991000045A1 WO1991000045A1 PCT/US1990/003591 US9003591W WO9100045A1 WO 1991000045 A1 WO1991000045 A1 WO 1991000045A1 US 9003591 W US9003591 W US 9003591W WO 9100045 A1 WO9100045 A1 WO 9100045A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- siv
- mno
- hiv
- proteins
- gp120env
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title abstract description 6
- 241000713311 Simian immunodeficiency virus Species 0.000 claims abstract description 16
- 241000700605 Viruses Species 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- 101800001466 Envelope glycoprotein E1 Proteins 0.000 claims description 9
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims description 9
- 206010061598 Immunodeficiency Diseases 0.000 claims description 4
- 208000029462 Immunodeficiency disease Diseases 0.000 claims description 4
- 230000007813 immunodeficiency Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000001900 immune effect Effects 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims 6
- 102000003886 Glycoproteins Human genes 0.000 claims 6
- 102100021696 Syncytin-1 Human genes 0.000 claims 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 230000008105 immune reaction Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 29
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000427 antigen Substances 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- 208000031886 HIV Infections Diseases 0.000 description 13
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 11
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 238000003119 immunoblot Methods 0.000 description 9
- 101710177291 Gag polyprotein Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- 101710125418 Major capsid protein Proteins 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 108010078428 env Gene Products Proteins 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010067390 Viral Proteins Proteins 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000004007 reversed phase HPLC Methods 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 241001635574 Sabatia angularis Species 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229960000789 guanidine hydrochloride Drugs 0.000 description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102100034353 Integrase Human genes 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 241000282553 Macaca Species 0.000 description 2
- 241000282561 Macaca nemestrina Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 108700004025 env Genes Proteins 0.000 description 2
- 101150030339 env gene Proteins 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000037230 mobility Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 230000006337 proteolytic cleavage Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- WONRDHPFOHAWOG-UHFFFAOYSA-N 2-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Cl)C=CC2=C1 WONRDHPFOHAWOG-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000282556 Cercocebus atys Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101710121417 Envelope glycoprotein Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 102100034349 Integrase Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101900350318 Simian immunodeficiency virus Surface protein gp120 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- FLNVBBPBGKOJHN-KKAOYSRWSA-N sivmac Chemical compound O=C([C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O FLNVBBPBGKOJHN-KKAOYSRWSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Des peptides sensiblement pures caractéristiques du virus d'immunodéficience simienne et des anticorps contre ce virus, utiles en tant que réactifs diagnostiques sont décrits.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37553589A | 1989-07-03 | 1989-07-03 | |
| US375,535 | 1989-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1991000045A1 true WO1991000045A1 (fr) | 1991-01-10 |
Family
ID=23481259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1990/003591 WO1991000045A1 (fr) | 1989-07-03 | 1990-06-29 | Reactif pour la detection de siv et hiv-2 |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5967090A (fr) |
| WO (1) | WO1991000045A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0452319A4 (fr) * | 1988-06-13 | 1991-09-02 | Us Secretary United States Dep | Nouvelle proteine et sequence de codage servant a la detection et a la differentiation du groupe des virus siv et hiv-2. |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
-
1990
- 1990-06-29 WO PCT/US1990/003591 patent/WO1991000045A1/fr unknown
- 1990-06-29 AU AU59670/90A patent/AU5967090A/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
Non-Patent Citations (4)
| Title |
|---|
| JOURNAL OF VIROLOGY, Volume 60, No. 2, issued November 1986, R.E. BENVENISTE et al., "Isolation of a Lentivirus from a Macoque with Lymphoma Comparison with HTLV-III/LAV and other Lentiviruses", pages 483-490. * |
| NATURE, Volume 321, issued 22 May 1986, M. MURPHY-CORB et al., "Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asympotomatic mangabeys", pages 435-437. * |
| NATURE, Volume 335, issued 15 September 1988, X.F. YU et al., "A naturally immunogenic Virion-associated protein specific for HIV-2 and SIV", pages 262-265. * |
| SCIENCE, Volume 232, issued 11 April 1986, P.J. KANKI et al., "New Human T-Lymphotopic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-IIIAGM)", pages 238-243. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0452319A4 (fr) * | 1988-06-13 | 1991-09-02 | Us Secretary United States Dep | Nouvelle proteine et sequence de codage servant a la detection et a la differentiation du groupe des virus siv et hiv-2. |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5967090A (en) | 1991-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1280363C (fr) | Compose peptidique et methode pour la detection des anticorps contre htlv-iii | |
| Putney et al. | HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope | |
| DK175901B1 (da) | Syntetiske HTLV-III peptider, sammensætninger, anvendelser samt fremgangsmåde til fremstilling deraf | |
| AU693098B2 (en) | Tandem synthetic HIV-1 peptides | |
| DE3588248T2 (de) | LAV-Antigene und -Peptide | |
| EP0214709B1 (fr) | Peptide synthétique et procédé pour son utilisation dans la détection d'anticorps de HTLV-III, le diagnostic de SIDA et pré-SIDA et comme vaccin | |
| EP0231914A2 (fr) | Peptides d'enveloppe de HTLV-III | |
| EP0247557B1 (fr) | Peptides enveloppé HTLV-III(LAV) | |
| CA1270756A (fr) | Virus t-lymphotrope | |
| EP0317804B1 (fr) | Peptides de VIH et méthodes de détection de VIH | |
| KR20020005675A (ko) | ＨＩＶ-1 Ｔａｔ 단백질의 전부 또는 일부를 함유하는항-ＨＩＶ-1 백신 | |
| US4957737A (en) | HTLV-III (LAV) envelope peptides | |
| AU654240B2 (en) | A method of eliciting the production of antibodies against HTLV-1 in mammals | |
| EP0335134B1 (fr) | Anticorps monoclonal de souris contre la protéine gp41 du virus d'immunodéficience humaine | |
| WO1991000045A1 (fr) | Reactif pour la detection de siv et hiv-2 | |
| JP2609448B2 (ja) | リンパ節症及び後天性免疫不全症候群のウイルスのエンベロープ抗原 | |
| Norrby et al. | Immunochemistry of the dominating antigenic region Ala582 to Cys604 in the transmembranous protein of simian and human immunodeficiency virus. | |
| AU617201B2 (en) | Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses | |
| HUT55035A (en) | Process for testing analogous peptides of hiv | |
| JPH08509597A (ja) | 診断に使用するためのｈｔｌｖ−▲ｉ▼およびｈｔｌｖ−▲ｉｉ▼ｇｐ２１由来ペプチド | |
| JP2001519800A (ja) | グループｏ ｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド | |
| GB2223226A (en) | A monoclonal antibody against HIV peptide | |
| EP0293792A2 (fr) | Protéines encodées par GAG du virus d'immunodéficience humaine | |
| CA1338028C (fr) | Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1 | |
| JPH05125096A (ja) | ペプチドおよびそれを含んでなるエイズ診断用要素 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
| COP | Corrected version of pamphlet |
Free format text: PAGES 1-14,DESCRIPTION,REPLACED BY NEW PAGES 1-13;PAGE 15,CLAIMS,REPLACED BY NEW PAGE 14;PAGES 1/3-3/3,DRAWINGS,REPLACED BY NEW PAGES 1/4-4/4;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |